These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2347652)

  • 1. A new low molecular weight heparinoid Org 10172 as anticoagulant in hemodialysis.
    Von Bonsdorff M; Stiekema J; Harjanne A; Alapiessa U
    Int J Artif Organs; 1990 Feb; 13(2):103-8. PubMed ID: 2347652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anticoagulant effect of heparinoid Org 10172 during haemodialysis: an objective assessment.
    Ireland H; Lane DA; Flynn A; Anastassiades E; Curtis JR
    Thromb Haemost; 1986 Apr; 55(2):271-5. PubMed ID: 3715791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulant effects of a low molecular weight heparinoid (Org 10172) in human volunteers and haemodialysis patients.
    ten Cate H; Henny CP; ten Cate JW; Büller HR; Mooy MC; Surachno S; Wilmink JM
    Thromb Res; 1985 Jul; 39(2):211-22. PubMed ID: 3161213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of a low molecular weight heparinoid in chronic intermittent haemodialysis.
    Henny CP; ten Cate H; Surachno S; Stevens P; Büller HR; den Hartog M; ten Cate JW
    Thromb Haemost; 1985 Aug; 54(2):460-2. PubMed ID: 2417351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized blind study comparing standard heparin and a new low molecular weight heparinoid in cardiopulmonary bypass surgery in dogs.
    Henny CP; Ten Cate H; Ten Cate JW; Moulijn AC; Sie TH; Warren P; Büller HR
    J Lab Clin Med; 1985 Aug; 106(2):187-96. PubMed ID: 4020247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heparin-induced thrombopenia during hemodialysis in intensive care: use of a low molecular weight heparinoid, ORG 10172 (Orgaran)].
    Mahul P; Raynaud J; Favre JP; Jospé R; Décousus H; Auboyer C
    Ann Fr Anesth Reanim; 1995; 14(1):29-32. PubMed ID: 7677282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ORG 10172: a low molecular weight heparinoid anticoagulant with a long half-life in man.
    Bradbrook ID; Magnani HN; Moelker HC; Morrison PJ; Robinson J; Rogers HJ; Spector RG; Van Dinther T; Wijnand H
    Br J Clin Pharmacol; 1987 Jun; 23(6):667-75. PubMed ID: 3606928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet activation following intravenous injection of a conventional heparin: absence of effect with a low molecular weight heparinoid (Org 10172).
    Mikhailidis DP; Fonseca VA; Barradas MA; Jeremy JY; Dandona P
    Br J Clin Pharmacol; 1987 Oct; 24(4):415-24. PubMed ID: 3689624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standard heparin versus low-molecular-weight heparin. A medium-term comparison in hemodialysis.
    Stefoni S; Cianciolo G; Donati G; Colì L; La Manna G; Raimondi C; Dalmastri V; Orlandi V; D'Addio F
    Nephron; 2002; 92(3):589-600. PubMed ID: 12372942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of fondaparinux as an anticoagulant during hemodialysis: a preliminary study.
    Sombolos KI; Fragia TK; Gionanlis LC; Veneti PE; Bamichas GI; Fragidis SK; Georgoulis IE; Natse TA
    Int J Clin Pharmacol Ther; 2008 Apr; 46(4):198-203. PubMed ID: 18397694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a new heparinoid as anticoagulant during acute haemodialysis of patients with bleeding complications.
    Henny CP; Ten Cate H; Ten Cate JW; Surachno S; van Bronswijk H; Wilmink JM; Ockelford PA
    Lancet; 1983 Apr; 1(8330):890-3. PubMed ID: 6132219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal blood loss in haemodialysis patients during use of a low-molecular-weight heparinoid anticoagulant.
    Frei U; Wilks MF; Boehmer S; Crisp-Lindgren N; Schwarzrock R; Stiekema JC; Koch KM
    Nephrol Dial Transplant; 1988; 3(4):435-9. PubMed ID: 2459635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose escalation study of ORG 10172 (low molecular weight heparinoid) in stroke.
    Biller J; Massey EW; Marler JR; Adams HP; Davis JN; Bruno A; Henriksen RA; Linhardt RJ; Goldstein LB; Alberts M
    Neurology; 1989 Feb; 39(2 Pt 1):262-5. PubMed ID: 2464774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant efficacy of PEG-Hirudin in patients on maintenance hemodialysis.
    Pöschel KA; Bucha E; Esslinger HU; Ulbricht K; Nörtersheuser P; Stein G; Nowak G
    Kidney Int; 2004 Feb; 65(2):666-74. PubMed ID: 14717940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of single dose low-molecular-weight heparin in long hemodialysis.
    Lai KN; Ho K; Li M; Szeto CC
    Int J Artif Organs; 1998 Apr; 21(4):196-200. PubMed ID: 9649059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parenteral anticoagulation with the heparinoid Lomoparan (Org 10172) in patients with heparin induced thrombocytopenia and thrombosis.
    Ortel TL; Gockerman JP; Califf RM; McCann RL; O'Connor CM; Metzler DM; Greenberg CS
    Thromb Haemost; 1992 Mar; 67(3):292-6. PubMed ID: 1379384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of a low molecular weight heparinoid (Org 10172) for extracorporeal procedures in patients with heparin dependent thrombocytopenia and thrombosis.
    Rowlings PA; Mansberg R; Rozenberg MC; Evans S; Murray B
    Aust N Z J Med; 1991 Feb; 21(1):52-4. PubMed ID: 1709804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-associated thrombocytopenia type II in a patient with end-stage renal disease: successful anticoagulation with the low-molecular-weight heparinoid Org 10172 during haemodialysis.
    Greinacher A; Philippen KH; Kemkes-Matthes B; Möckl M; Mueller-Eckhardt C; Schaefer K
    Nephrol Dial Transplant; 1993; 8(10):1176-7. PubMed ID: 7505906
    [No Abstract]   [Full Text] [Related]  

  • 19. Time courses of the antithrombotic effects, bleeding enhancing effects and interactions with factors Xa and thrombin after administration of low molecular weight heparinoid Org 10172 or heparin to rats.
    Hobbelen PM; Vogel GM; Meuleman DG
    Thromb Res; 1987 Dec; 48(5):549-58. PubMed ID: 3481660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of low-dose low molecular weight heparin in hemodialysis.
    Lai KN; Wang AY; Ho K; Szeto CC; Li M; Wong LK; Yu AW
    Am J Kidney Dis; 1996 Nov; 28(5):721-6. PubMed ID: 9158210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.